Laboratory Corp Of America Holdings

Labcorp Holdings Inc. (NYSE: LH) is a global laboratory services company operating through two primary segments: Diagnostics Laboratories and Biopharma Laboratory Services. The Diagnostics Laboratories segment provides a broad range of clinical laboratory tests used by healthcare providers to detect, diagnose, and monitor disease, including specialty testing in areas such as oncology, neurology, and women's health. The Biopharma Laboratory Services segment offers central laboratory and early development services supporting pharmaceutical and biotechnology companies in their drug development and clinical trial programs. With approximately 71,000 employees serving clients in roughly 100 countries, the company provided support for more than 85% of new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests annually. Labcorp is actively expanding through acquisitions, innovation in companion diagnostics and precision medicine, and direct-to-consumer testing through its Labcorp OnDemand platform, which offers over 140 panels and tests. Updated Oct 28, 2026